Publicacións nas que colabora con María Jesús Paniagua Martín (17)

2024

  1. Reduced mitochondrial pyruvate carrier expression in hearts with heart failure and reduced ejection fraction patients: ischemic vs. non-ischemic origin

    Frontiers in Cardiovascular Medicine, Vol. 11

2023

  1. Soluble HLA-G levels in heart transplant recipients: Dynamics and correlation with clinical outcomes

    Transplant Immunology, Vol. 76

2020

  1. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 39, Núm. 10, pp. 1100-1108

2019

  1. AGT haplotype in ITGA4 gene is related to antibody-mediated rejection in heart transplant patients

    PLoS ONE, Vol. 14, Núm. 7

  2. Circulating Galectin-3 Following Heart Transplant: Long-term Dynamics and Prognostic Value

    Revista Espanola de Cardiologia, Vol. 72, Núm. 11, pp. 899-906

2018

  1. Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection

    Journal of Heart and Lung Transplantation, Vol. 37, Núm. 4, pp. 477-485

2016

  1. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report

    Cardiology Journal, Vol. 23, Núm. 5, pp. 573-582

2013

  1. Mitochondrial DNA haplogroup H as a risk factor for idiopathic dilated cardiomyopathy in Spanish population

    Mitochondrion, Vol. 13, Núm. 4, pp. 263-268

2012

  1. Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation

    Transplantation Proceedings

  2. Mitochondrial Haplogroups H and J: Risk and Protective Factors for Ischemic Cardiomyopathy

    PLoS ONE, Vol. 7, Núm. 8

2009

  1. Gene Expression Profiling for Monitoring Graft Rejection in Heart Transplant Recipients

    Transplantation Proceedings, Vol. 41, Núm. 6, pp. 2240-2243

2007

  1. Identification of a cardiac allograft rejection marker using microarray gene expression analysis in lymphocytes from heart transplant patients [4]

    Revista Espanola de Cardiologia

2005

  1. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): Incidence, management, and the value of C4d for diagnosis

    American Journal of Transplantation, Vol. 5, Núm. 10, pp. 2560-2564

2004

  1. Severe cardiac allograft dysfunction without endomyocardial biopsy signs of cellular rejection: Incidence and management

    Transplantation Proceedings

2003

  1. Neither acute rejection nor immunosuppressant drug therapy (cyclosporine or tacrolimus) correlates with expression of either CD40 or CD154 on peripheral blood cells among human cardiac transplant patients

    Transplantation Proceedings

2002

  1. Microchimerism after heart transplantation: Prevalence, predisposing factors, natural history, and prognosis

    Transplantation Proceedings, Vol. 34, Núm. 1, pp. 161-163

1998

  1. Cytomegalovirus colitis mimicking a colonic neoplasm or ischemic colitis 4 years after heart transplantation

    Transplantation, Vol. 66, Núm. 11, pp. 1562-1565